73 related articles for article (PubMed ID: 12200354)
1. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F
Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Sobas M; Knopinska-Posluszny W; Piątkowska-Jakubas B; García-Álvarez F; Díez MEA; Caballero M; Martínez-Cuadrón D; Aguiar E; González-Campos J; Garrido A; Algarra L; Salamero O; de la Serna J; Sayas MJ; Perez-Encinas MM; Vives S; Vidriales B; Labrador J; Prado AI; Celebrin L; Mayer J; Brioso J; de Laiglesia A; Bergua JM; Amigo ML; Rodriguez-Medina C; Polo M; Pluta A; Cichocka E; Skarupski M; Sanz MA; Wierzbowska A; Montesinos P
Ann Hematol; 2024 Feb; 103(2):451-461. PubMed ID: 38110588
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of the SCMC APL-2010 regimen in treatment of acute promyelocytic leukemia in children: an analysis of 44 cases].
Wang Z; Shen SH; Tang YJ; Xue HL; Hu WT; Pan C; Tang JY; Gu LJ; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Nov; 21(11):1073-1078. PubMed ID: 31753087
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre.
Karim F; Shaikh U; Adil SN; Khurshid M
Singapore Med J; 2014 Aug; 55(8):443-7. PubMed ID: 25189308
[TBL] [Abstract][Full Text] [Related]
5. Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.
Abrahão R; Ribeiro RC; Medeiros BC; Keogh RH; Keegan TH
Cancer; 2015 Nov; 121(22):3990-7. PubMed ID: 26264598
[TBL] [Abstract][Full Text] [Related]
6. Global characteristics of childhood acute promyelocytic leukemia.
Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial.
Yin JA; O'Brien MA; Hills RK; Daly SB; Wheatley K; Burnett AK
Blood; 2012 Oct; 120(14):2826-35. PubMed ID: 22875911
[TBL] [Abstract][Full Text] [Related]
8. Adult acute myeloid leukaemia.
Smith M; Barnett M; Bassan R; Gatta G; Tondini C; Kern W
Crit Rev Oncol Hematol; 2004 Jun; 50(3):197-222. PubMed ID: 15182826
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical Evaluation.
Palmieri R; Paterno G; Mallegni F; Frenza F; De Bernardis I; Moretti F; Meddi E; Del Principe MI; Maurillo L; Venditti A; Buccisano F
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023051. PubMed ID: 37705524
[TBL] [Abstract][Full Text] [Related]
10. Therapy-Related Acute Promyelocytic Leukemia: A Case Report and a Review of Literature.
Foster D; Nair HK; Robbins K; Rajeh N
Cureus; 2023 Jul; 15(7):e42008. PubMed ID: 37593318
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia current treatment algorithms.
Yilmaz M; Kantarjian H; Ravandi F
Blood Cancer J; 2021 Jun; 11(6):123. PubMed ID: 34193815
[TBL] [Abstract][Full Text] [Related]
12. Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient.
Perrone S; Ortu La Barbera E; Ottone T; Capriata M; Passucci M; Filippi L; Bagni O; Voso MT; Cimino G
Nucl Med Mol Imaging; 2020 Oct; 54(5):256-260. PubMed ID: 33088356
[No Abstract] [Full Text] [Related]
13. Therapy-related acute promyelocytic leukemia with FMS-like tyrosine kinase 3-internal tandem duplication mutation in solitary bone plasmacytoma: A case report.
Hong LL; Sheng XF; Zhuang HF
World J Clin Cases; 2020 Oct; 8(19):4579-4587. PubMed ID: 33083421
[TBL] [Abstract][Full Text] [Related]
14. Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia.
Li G; Gao Y; Li K; Lin A; Jiang Z
Oncol Lett; 2020 Aug; 20(2):1824-1834. PubMed ID: 32724426
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.
Kuendgen A; Nomdedeu M; Tuechler H; Garcia-Manero G; Komrokji RS; Sekeres MA; Della Porta MG; Cazzola M; DeZern AE; Roboz GJ; Steensma DP; Van de Loosdrecht AA; Schlenk RF; Grau J; Calvo X; Blum S; Pereira A; Valent P; Costa D; Giagounidis A; Xicoy B; Döhner H; Platzbecker U; Pedro C; Lübbert M; Oiartzabal I; Díez-Campelo M; Cedena MT; Machherndl-Spandl S; López-Pavía M; Baldus CD; Martinez-de-Sola M; Stauder R; Merchan B; List A; Ganster C; Schroeder T; Voso MT; Pfeilstöcker M; Sill H; Hildebrandt B; Esteve J; Nomdedeu B; Cobo F; Haas R; Sole F; Germing U; Greenberg PL; Haase D; Sanz G
Leukemia; 2021 Mar; 35(3):835-849. PubMed ID: 32595214
[TBL] [Abstract][Full Text] [Related]
16. Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
Hattori H; Ishikawa Y; Kawashima N; Akashi A; Yamaguchi Y; Harada Y; Hirano D; Adachi Y; Miyao K; Ushijima Y; Terakura S; Nishida T; Matsushita T; Kiyoi H
PLoS One; 2018; 13(10):e0204850. PubMed ID: 30289902
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related acute promyelocytic leukemia in plasma cell myeloma treated with melphalan: a case report and literature review.
Gu H; Kim YJ; Lee WI; Lee J; Yoon HJ; Park TS
Blood Res; 2017 Mar; 52(1):62-64. PubMed ID: 28401104
[No Abstract] [Full Text] [Related]
18. Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.
Kayser S; Krzykalla J; Elliott MA; Norsworthy K; Gonzales P; Hills RK; Baer MR; Ráčil Z; Mayer J; Novak J; Žák P; Szotkowski T; Grimwade D; Russell NH; Walter RB; Estey EH; Westermann J; Görner M; Benner A; Krämer A; Smith BD; Burnett AK; Thiede C; Röllig C; Ho AD; Ehninger G; Schlenk RF; Tallman MS; Levis MJ; Platzbecker U
Leukemia; 2017 Nov; 31(11):2347-2354. PubMed ID: 28322237
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.
Sasaki K; Jabbour E; Cortes J; Kadia T; Garcia-Manero G; Borthakur G; Jain P; Pierce S; Daver N; Takahashi K; O'Brien S; Kantarjian H; Ravandi F
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):616-624. PubMed ID: 27601000
[TBL] [Abstract][Full Text] [Related]
20. CD34(+) therapy-related acute promyelocytic leukemia in a patient previously treated for breast cancer.
Savooji J; Shakil F; Islam H; Liu D; Seiter K
Stem Cell Investig; 2016; 3():7. PubMed ID: 27358899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
